Author:
Chen Lei,Lu Jing,Huang Tao,Yin Jun,Wei Lai,Cai Yu-Dong
Publisher
Public Library of Science (PLoS)
Reference48 articles.
1. Treatment of chronic hepatitis C: a systematic review;G Chander;Hepatology,2002
2. Approval of Incivek (telaprevir), a direct acting antiviral drug (DAA) to treat hepatitis C (HCV). Available: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/ucm256328.htm. Accessed 2014 March 7.
3. Approval of Victrelis (boceprevir) a direct acting antiviral drug (DAA) to treat hepatitis C virus (HCV). Available: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/ucm255413.htm. Accessed 2014 March 7.
4. Antiviral treatment of hepatitis C virus infection and factors affecting efficacy;Y Zhu;World J Gastroenterol,2013
5. Mutagenic probability estimation of chemical compounds by a novel molecular electrophilicity vector and support vector machine;M Zheng;Bioinformatics,2006
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献